Sartor RB - Search Results

1

Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease.

Fornelos N, Franzosa EA, Bishai J, Annand JW, Oka A, Lloyd-Price J, Arthur TD, Garner A, Avila-Pacheco J, Haiser HJ, Tolonen AC, Porter JA, Clish CB, Sartor RB, Huttenhower C, Vlamakis H, Xavier RJ. Fornelos N, et al. Among authors: sartor rb. Nat Microbiol. 2020 Mar;5(3):486-497. doi: 10.1038/s41564-019-0655-7. Epub 2020 Jan 20. Nat Microbiol. 2020. PMID: 31959971 Free PMC article.

2

Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.

Sartor RB. Sartor RB. Am J Gastroenterol. 1997 Dec;92(12 Suppl):5S-11S. Am J Gastroenterol. 1997. PMID: 9395346 Review.

3

Microbial influences in inflammatory bowel diseases.

Sartor RB. Sartor RB. Gastroenterology. 2008 Feb;134(2):577-94. doi: 10.1053/j.gastro.2007.11.059. Gastroenterology. 2008. PMID: 18242222 Review.

4

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.

Packey CD, Sartor RB. Packey CD, et al. Among authors: sartor rb. Curr Opin Infect Dis. 2009 Jun;22(3):292-301. doi: 10.1097/QCO.0b013e32832a8a5d. Curr Opin Infect Dis. 2009. PMID: 19352175 Free PMC article. Review.

5

The intestinal microbiota in inflammatory bowel diseases.

Sartor RB. Sartor RB. Nestle Nutr Inst Workshop Ser. 2014;79:29-39. doi: 10.1159/000360674. Epub 2014 Sep 5. Nestle Nutr Inst Workshop Ser. 2014. PMID: 25227293

6

Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases.

Sartor RB. Sartor RB. Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:27-36. doi: 10.1111/apt.13436. Aliment Pharmacol Ther. 2016. PMID: 26618923 Review.

7

Characterization of candidate genes in inflammatory bowel disease-associated risk loci.

Peloquin JM, Goel G, Kong L, Huang H, Haritunians T, Sartor RB, Daly MJ, Newberry RD, McGovern DP, Yajnik V, Lira SA, Xavier RJ. Peloquin JM, et al. Among authors: sartor rb. JCI Insight. 2016 Aug 18;1(13):e87899. doi: 10.1172/jci.insight.87899. JCI Insight. 2016. PMID: 27668286 Free PMC article.

8

Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

Sartor RB, Wu GD. Sartor RB, et al. Gastroenterology. 2017 Feb;152(2):327-339.e4. doi: 10.1053/j.gastro.2016.10.012. Epub 2016 Oct 18. Gastroenterology. 2017. PMID: 27769810 Free PMC article. Review.

9

Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice.

Schulfer AF, Battaglia T, Alvarez Y, Bijnens L, Ruiz VE, Ho M, Robinson S, Ward T, Cox LM, Rogers AB, Knights D, Sartor RB, Blaser MJ. Schulfer AF, et al. Among authors: sartor rb. Nat Microbiol. 2018 Feb;3(2):234-242. doi: 10.1038/s41564-017-0075-5. Epub 2017 Nov 27. Nat Microbiol. 2018. PMID: 29180726 Free PMC article.

10

A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells.

Chang YL, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, Humphries R, Stappenbeck T, Simpson KW, Sartor RB, Wu G, Lewis J, Bushman F, McGovern DPB, Salzman N, Borneman J, Xavier R, Huttenhower C, Braun J. Chang YL, et al. Among authors: sartor rb. Mucosal Immunol. 2019 Mar;12(2):457-467. doi: 10.1038/s41385-018-0022-7. Epub 2018 Apr 25. Mucosal Immunol. 2019. PMID: 29695840 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters